Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Graft Rejection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07516379
What this trial is testing

GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

Who this might be right for
Lung TransplantEnd Stage Lung DiseaseRejection
National Heart, Lung, and Blood Institute (NHLBI) 100
Not applicableLooking for participantsNCT01531257
What this trial is testing

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Who this might be right for
Acute Rejection (AR) of Transplanted KidneyChronic Allograft Nephropathy (CAN)Interstitial Fibrosis (IF)+1 more
Northwestern University 1,000
Not applicableLooking for participantsNCT06830473
What this trial is testing

KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection

Who this might be right for
Kidney TransplantKidney Disease, Chronic
University of Edinburgh 200
Not applicableStudy completedNCT06216015
What this trial is testing

Exercise Training and Kidney Transplantation

Who this might be right for
Solid Organ Transplant RejectionChronic Kidney FailureQuality of Life+2 more
Hugo de Luca Correa 345
Not applicableLooking for participantsNCT07434869
What this trial is testing

Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD

Who this might be right for
Lung Transplant Failure and RejectionCLAD, Bronchiolitis ObliteransExtracorporeal Photopheresis
Brian Keller 25
Post-approval studies (Phase 4)Study completedNCT00510913
What this trial is testing

Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

Who this might be right for
Graft RejectionKidney Transplantation
Astellas Pharma Inc 450
Post-approval studies (Phase 4)Study completedNCT00807144
What this trial is testing

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation

Who this might be right for
End-stage Renal FailureGraft Rejection
Imperial College Healthcare NHS Trust 102
Not applicableNot Yet RecruitingNCT07005687
What this trial is testing

Using MSCs for Chronic Active Antibody Mediated Rejection

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 10
Not applicableActive Not RecruitingNCT03859388
What this trial is testing

Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

Who this might be right for
Rejection Chronic RenalKidney Transplant Rejection
Cedars-Sinai Medical Center 10
Large-scale testing (Phase 3)Active Not RecruitingNCT04561986
What this trial is testing

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
Vastra Gotaland Region 50
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05285878
What this trial is testing

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Interstitial FibrosisKidney Transplant; ComplicationsKidney Transplant Rejection+4 more
The Methodist Hospital Research Institute 20
Post-approval studies (Phase 4)Study completedNCT00656695
What this trial is testing

Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation

Who this might be right for
End Stage Renal DiseaseRenal Transplantation
Imam Khomeini Hospital 208
Early research (Phase 1)UnknownNCT06514378
What this trial is testing

Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction

Who this might be right for
Chronic Lung DiseaseLung Transplant Rejection
Instituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana 12
Not applicableUnknownNCT05061303
What this trial is testing

Omeprazole and Famotidine in Chronic Dysfunction of the Transplanted Kidney

Who this might be right for
Kidney Rejection Transplant
Poznan University of Medical Sciences 24
Testing effectiveness (Phase 2)Ended earlyNCT05550662
What this trial is testing

HP 129Xe MRI for Evaluation of CLAD in Lung Transplant Recipients

Who this might be right for
Lung Transplant Rejection
The Hospital for Sick Children 6
Not applicableEnded earlyNCT00746057
What this trial is testing

Evaluation of an Early Screening Test of Chronic Rejection and of Operational Tolerance by MicroArray in Renal Graft (Protocol DPRC Array)

Who this might be right for
First Cadaveric Renal Graft
Nantes University Hospital 134
Not applicableStudy completedNCT00056784
What this trial is testing

The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation

Who this might be right for
Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 134
Not applicableActive Not RecruitingNCT07805343
What this trial is testing

Extended Validation of Donor-derived Cell-free DNA in Kidney Transplant Recipients

Who this might be right for
Rejection Acute RenalRejection Chronic RenalTransplantation+1 more
Paris Translational Research Center for Organ Transplantation 5,000
Testing effectiveness (Phase 2)Study completedNCT00079391
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Who this might be right for
Hematologic MalignanciesBone Marrow Transplant Rejection
National Heart, Lung, and Blood Institute (NHLBI) 50
Not applicableActive Not RecruitingNCT05112315
What this trial is testing

Clinical Impact of the IBox As an Early Intervention TooL

Who this might be right for
Kidney DiseasesKidney Disease, ChronicKidney Transplant Rejection+4 more
Predict4Health 507
Next Page